| Symbol |
Name |
|
AAMP
|
angio-associated, migratory cell protein
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AGTRAP
|
angiotensin II receptor-associated protein
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPP
|
alkaline phosphatase, placental
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL1
|
angiopoietin-like 1
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANTXR1
|
anthrax toxin receptor 1
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
APOA1
|
apolipoprotein A-I
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARG1
|
arginase 1
|
|
ARG2
|
arginase 2
|
|
ARHGAP42
|
Rho GTPase activating protein 42
|
|
ARHGEF11
|
Rho guanine nucleotide exchange factor (GEF) 11
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa
|
|
ARPC3
|
actin related protein 2/3 complex, subunit 3, 21kDa
|
|
ARRB2
|
arrestin, beta 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
AZU1
|
azurocidin 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C3AR1
|
complement component 3a receptor 1
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALD1
|
caldesmon 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD38
|
CD38 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEL
|
carboxyl ester lipase
|
|
CENPB
|
centromere protein B, 80kDa
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHN2
|
chimerin 2
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CIAPIN1
|
cytokine induced apoptosis inhibitor 1
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CKLF
|
chemokine-like factor
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLDN1
|
claudin 1
|
|
CLEC11A
|
C-type lectin domain family 11, member A
|
|
CLIC4
|
chloride intracellular channel 4
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CNN1
|
calponin 1, basic, smooth muscle
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
COMT
|
catechol-O-methyltransferase
|
|
CORT
|
cortistatin
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CRIP2
|
cysteine-rich protein 2
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK3
|
death-associated protein kinase 3
|
|
DCN
|
decorin
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DES
|
desmin
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
E2F1
|
E2F transcription factor 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EHF
|
ets homologous factor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
ENG
|
endoglin
|
|
EP300
|
E1A binding protein p300
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FAM172A
|
family with sequence similarity 172, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLN5
|
fibulin 5
|
|
FBN1
|
fibrillin 1
|
|
FBXO32
|
F-box protein 32
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FETUB
|
fetuin B
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFRL1
|
fibroblast growth factor receptor-like 1
|
|
FHOD1
|
formin homology 2 domain containing 1
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FN1
|
fibronectin 1
|
|
FNTA
|
farnesyltransferase, CAAX box, alpha
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXH1
|
forkhead box H1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FSTL1
|
follistatin-like 1
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA6
|
GATA binding protein 6
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GDF5
|
growth differentiation factor 5
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJC1
|
gap junction protein, gamma 1, 45kDa
|
|
GMFG
|
glia maturation factor, gamma
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR68
|
G protein-coupled receptor 68
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRK6
|
G protein-coupled receptor kinase 6
|
|
GRP
|
gastrin-releasing peptide
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSR
|
glutathione reductase
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC8
|
histone deacetylase 8
|
|
HDC
|
histidine decarboxylase
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMGXB4
|
HMG box domain containing 4
|
|
HMOX1
|
heme oxygenase 1
|
|
HOXA10
|
homeobox A10
|
|
HOXA4
|
homeobox A4
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRC
|
histidine rich calcium binding protein
|
|
HRG
|
histidine-rich glycoprotein
|
|
HRH1
|
histamine receptor H1
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IHH
|
indian hedgehog
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL19
|
interleukin 19
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL22
|
interleukin 22
|
|
IL24
|
interleukin 24
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAZF1
|
JAZF zinc finger 1
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KCNA10
|
potassium channel, voltage gated shaker related subfamily A, member 10
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNB2
|
potassium channel, voltage gated Shab related subfamily B, member 2
|
|
KCNC4
|
potassium channel, voltage gated Shaw related subfamily C, member 4
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNJ14
|
potassium channel, inwardly rectifying subfamily J, member 14
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNJ9
|
potassium channel, inwardly rectifying subfamily J, member 9
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ5
|
potassium channel, voltage gated KQT-like subfamily Q, member 5
|
|
KCNS3
|
potassium voltage-gated channel, modifier subfamily S, member 3
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF15
|
Kruppel-like factor 15
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KNG1
|
kininogen 1
|
|
KRT18
|
keratin 18, type I
|
|
KRT8
|
keratin 8, type II
|
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIMK1
|
LIM domain kinase 1
|
|
LMNA
|
lamin A/C
|
|
LMOD1
|
leiomodin 1 (smooth muscle)
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LPXN
|
leupaxin
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LYZ
|
lysozyme
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MB
|
myoglobin
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED12
|
mediator complex subunit 12
|
|
MED28
|
mediator complex subunit 28
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MFN2
|
mitofusin 2
|
|
MGP
|
matrix Gla protein
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR10A
|
microRNA 10a
|
|
MIR140
|
microRNA 140
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR15A
|
microRNA 15a
|
|
MIR15B
|
microRNA 15b
|
|
MIR17
|
microRNA 17
|
|
MIR18B
|
microRNA 18b
|
|
MIR200C
|
microRNA 200c
|
|
MIR206
|
microRNA 206
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR223
|
microRNA 223
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR31
|
microRNA 31
|
|
MIR424
|
microRNA 424
|
|
MIR638
|
microRNA 638
|
|
MIR663A
|
microRNA 663a
|
|
MIRLET7B
|
microRNA let-7b
|
|
MIRLET7G
|
microRNA let-7g
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLNR
|
motilin receptor
|
|
MLST8
|
MTOR associated protein, LST8 homolog (S. cerevisiae)
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPRIP
|
myosin phosphatase Rho interacting protein
|
|
MRVI1
|
murine retrovirus integration site 1 homolog
|
|
MSRB2
|
methionine sulfoxide reductase B2
|
|
MSX2
|
msh homeobox 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYLK
|
myosin light chain kinase
|
|
MYOCD
|
myocardin
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCF1C
|
neutrophil cytosolic factor 1C pseudogene
|
|
NDRG4
|
NDRG family member 4
|
|
NES
|
nestin
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKRF
|
NFKB repressing factor
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NKX6-1
|
NK6 homeobox 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NOXA1
|
NADPH oxidase activator 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPC
|
natriuretic peptide C
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NTF3
|
neurotrophin 3
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OSM
|
oncostatin M
|
|
OXTR
|
oxytocin receptor
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
P4HA1
|
prolyl 4-hydroxylase, alpha polypeptide I
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PGF
|
placental growth factor
|
|
PGGT1B
|
protein geranylgeranyltransferase type I, beta subunit
|
|
PGR
|
progesterone receptor
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PKN1
|
protein kinase N1
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLG
|
plasminogen
|
|
PLIN2
|
perilipin 2
|
|
PLK1
|
polo-like kinase 1
|
|
PML
|
promyelocytic leukemia
|
|
PODN
|
podocan
|
|
PODXL
|
podocalyxin-like
|
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PREB
|
prolactin regulatory element binding
|
|
PRG4
|
proteoglycan 4
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROS1
|
protein S (alpha)
|
|
PRSS22
|
protease, serine, 22
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2
|
|
RANBP1
|
RAN binding protein 1
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RB1
|
retinoblastoma 1
|
|
RBP1
|
retinol binding protein 1, cellular
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RETN
|
resistin
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RHOD
|
ras homolog family member D
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RTN4
|
reticulon 4
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR3
|
ryanodine receptor 3
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SAA1
|
serum amyloid A1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDC3
|
syndecan 3
|
|
SDC4
|
syndecan 4
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SEMA3G
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPD
|
surfactant protein D
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHH
|
sonic hedgehog
|
|
SIN3B
|
SIN3 transcription regulator family member B
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC18A1
|
solute carrier family 18 (vesicular monoamine transporter), member 1
|
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A12
|
solute carrier family 2 (facilitated glucose transporter), member 12
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD5
|
SMAD family member 5
|
|
SMAD9
|
SMAD family member 9
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMTN
|
smoothelin
|
|
SMTNL1
|
smoothelin-like 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHKAP
|
SPHK1 interactor, AKAP domain containing
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR3
|
small proline-rich protein 3
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRI
|
sorcin
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
SUMF2
|
sulfatase modifying factor 2
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYNE2
|
spectrin repeat containing, nuclear envelope 2
|
|
SYNM
|
synemin, intermediate filament protein
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TACR3
|
tachykinin receptor 3
|
|
TAF6L
|
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa
|
|
TAGLN
|
transgelin
|
|
TAS2R1
|
taste receptor, type 2, member 1
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TDG
|
thymine-DNA glycosylase
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TJP2
|
tight junction protein 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TMTC3
|
transmembrane and tetratricopeptide repeat containing 3
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TRIB1
|
tribbles pseudokinase 1
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D1
|
TSC22 domain family, member 1
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPAN9
|
tetraspanin 9
|
|
TTN
|
titin
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCN
|
urocortin
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UNC5B
|
unc-5 homolog B (C. elegans)
|
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast)
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
USP5
|
ubiquitin specific peptidase 5 (isopeptidase T)
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIMP
|
VCP-interacting membrane selenoprotein
|
|
VTN
|
vitronectin
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
WTAP
|
Wilms tumor 1 associated protein
|
|
YIPF5
|
Yip1 domain family, member 5
|
|
YY1
|
YY1 transcription factor
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZDHHC8
|
zinc finger, DHHC-type containing 8
|
